- Home
- STAA vs OPK Comparison
STAA vs OPK Comparison
Compare STAA & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STAA | OPK |
|---|---|---|
| Founded | 1982 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 867.9M | 921.2M |
| IPO Year | 1995 | 2011 |
Fundamental Metrics
Financial Performance| Metric | STAA | OPK |
|---|---|---|
| Price | $17.83 | $1.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $21.61 | $2.03 |
| AVG Volume (30 Days) | 1.2M | ★ 1.9M |
| Earning Date | 05-28-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $239,442,000.00 | ★ $606,879,000.00 |
| Revenue This Year | $33.83 | N/A |
| Revenue Next Year | $8.16 | $4.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.69 | $1.11 |
| 52 Week High | $30.81 | $1.87 |
Technical Indicators
Market Signals| Indicator | STAA | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 43.72 | 48.65 |
| Support Level | $17.13 | $1.12 |
| Resistance Level | $18.19 | $1.27 |
| Average True Range (ATR) | 0.89 | 0.04 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 21.41 | 50.00 |
Price Performance
Historical ComparisonAbout STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.